Venus to sell Meropenem in Australia; ties up with Lupin

Pharma major Venus Remedies Ltd today said it has received marketing authorisation for its antibiotic drug Meropenem from Australian regulator TGA and has tied up with Lupin to sell the drug there.

The Panchkula-based company said it plans to roll out the drug by the third quarter of 2014 and is eyeing sizeable share in Australia's $15 million Meropenem market in the first year of launch.

"The marketing authorisation from TGA (Therapeutic Goods Administration) has once again proved the company's capabilities in developing world-class products that meet the most stringent regulatory requirements," said Venus Chairman and MD Pawan Chaudhary in a statement.

He said the company has tied-up with Lupin to market this drug in Australia.

Meropenem is an off-patent antibacterial agent of carbapenem class of antibiotics that caters to diseases with a broad range of serious infections caused by single or multiple susceptible bacteria in both adults and children.

Venus Remedies is already selling Meropenem in lucrative markets like Europe, New Zealand and Saudi Arabia. It is also in the process of extending sales operations to other regulated markets like Canada and Switzerland, Chaudhary said.

With marketing approvals from more than 35 countries, Venus Remedies is poised to capture a significant share in the $1.3 billion global Meropenem market, he said.

EDITORIAL OF THE DAY

  • Because our politicians elbowed out our teachers on Teachers’ Day

    The Swachch Bharat campaign made the highest leaders sweep. Teachers’ Day is making them teach.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Sachin Shridhar

Crouching tiger, hidden dragon

The Chinese are consummate gamblers. If you visit a casino ...

Zehra Naqvi

Capturing change

The pace of change in the world around us can ...

Gautam Gupta

Bring on the Benares brigade

It was in 2003 when I first started work and ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture